“LDL cholesterol doesn’t cause heart disease.”
Strong confidence because converging genetic, epidemiologic, mechanistic and randomized-treatment evidence supports a causal and cumulative role for LDL-containing particles in atherosclerotic cardiovascular disease. Trial meta-analysis shows fewer major vascular events as LDL cholesterol is lowered.
LDL-containing particles play a causal role in atherosclerosis. Risk rises with the concentration of atherogenic particles and the duration of exposure, while randomized LDL-lowering trials reduce heart attacks, ischemic strokes and related procedures.
LDL is not the only cause of cardiovascular disease, and LDL cholesterol is an imperfect proxy for particle number in some people. Blood pressure, smoking, diabetes, kidney disease, inflammation, age and family history also shape absolute risk.
Safety note: A causal risk factor does not mean everyone with the same LDL needs the same medicine or target. Treatment benefit and adverse effects depend on baseline risk, degree of reduction, age, pregnancy status, other conditions and patient preferences.
Talk to a healthcare professional if: Discuss markedly elevated LDL, premature cardiovascular disease in the family, diabetes, kidney disease or uncertainty about treatment with a clinician. Do not stop prescribed lipid-lowering therapy based on online claims.
LDL is a treatment-relevant cause of atherosclerotic disease, while your personal decision still depends on absolute risk and the whole clinical picture.
Review an up-to-date lipid panel and cardiovascular-risk assessment with a clinician, then decide on lifestyle and medication based on expected absolute benefit and your preferences.